Article
Repurposing Live Attenuated Trivalent MMR Vaccine as Cost-effective Cancer Immunotherapy
2022-03-01
Abstract excerpt
<h4>ABSTRACT</h4> Despite its rising promise, cancer immunotherapy remains out of reach for many patients because of the extensive cost of manufacturing immunotherapy products. In this study, we show that intratumoral injections of the trivalent measles, mumps, and rubella (MMR) live attenuated viral vaccine (LAVs) modulates a potent cytotoxic T-cell antitumor immune response, resulting in tumor growth inhibition...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c22c5717-35fb-579b-8c50-805b6030d333
- DOI
- 10.1101/2022.02.25.481685
